Nanoform Capacity Update February 2024: Small Molecule

The presentation from the February 2024 OPCU event introduces Nanoform, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients. Case studies will show how nanoparticles can enable faster onset of oral medications, reduce initial burst, extend the therapeutic window of long-acting implants, and increase drug loading in hydrogel formulations. Bioequivalence of a nanocrystalline formulation with an amorphous dispersion, and an ongoing clinical study will also be announced. Delve into Nanoform’s manufacturing capabilities, including ongoing and planned GMP expansion for highly-potent APIs.